Medicare
The Medicare Payment Advisory Commission (MedPAC, or the Commission) will vote this month on payment recommendations for 2021. The American Hospital Association (AHA) asks that commissioners consider the following issues that would have a significant impact on hospitals, health systems, other…
The Centers for Medicare & Medicaid Services has delayed 2020 private payer data reporting for the Clinical Diagnostic Test Payment System until 2021 for tests that are not advanced diagnostic laboratory tests, as required by recent legislation extending funding for federal programs through…
Hospitals participating in the Medicare Bundled Payment for Care Improvement Program reduced spending for lower extremity joint replacements over three years by an average 1.6 percent more than hospitals that did not participate, with no change in quality, according to a study reported last week in…
HHS remains on track to meet the reduction targets set forth in the Court’s November 1 Order.
AHA urges CMS to reconsider its recent guidance to providers requiring them to document Medicare-Medicaid “crossover” bad debt in a manner that is neither standard practice for most hospitals nor consistent with current accounting standards.
Less than 1% of the net electronic health record incentive payments Medicare paid to acute-care hospitals between Jan. 1, 2013 and Sept. 30, 2017 did not meet federal requirements.
By proposing a new safe harbor for patient engagement tools and creating three new safe harbors for value-based arrangements, the Department of Health and Human Services Office of Inspector General has taken “the first steps toward much needed reform” of the federal anti-kickback statute and civil…
The AHA applauded “the new direction” the Centers for Medicare & Medicaid Services is taking to modify, modernize and clarify the physician self-referral law, also known as the Stark Law, to “provide space for the types of innovative arrangements among hospitals and physicians that can enhance…
The House of Representatives today voted 230-192 to approve the Lower Prescription Drug Costs Now Act.